Trademark: 79185231
Word
MMPROFILER
Status Date
Wednesday, November 9, 2016
Filing Date
Thursday, October 22, 2015
Abandoned Date
Monday, October 3, 2016
9 Software; software and algorithms for performing diagnostic tests for medical purposes; software for generating and reading out of the (complex) genetic properties of the patient sample; software for interpreting the obtained raw genetic information for inter alia laboratory users, molecular biologists, pathologists, physicians and patients, comprehensive and relevant information (such as the presence of a genetic aberration, mutation, or gene expression profile, genetic subtype of the disease or clinical consequence thereof as well as poor or good prognosis, whether or not in combination with a specific treatment); validated software for secure IT infrastructures for clinical purposes; databases containing anonymous genetic data of patients from clinical studies for comparison with the genetic outcome of patients samples
5 Molecular diagnostic test reagents; molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer; molecular diagnostic test reagents, inter alia on the basis of microarray technology (next generation) sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile, reagents for use in medical genetic testing for the measurement of gene aberrations and mutations, clinical multiplex (research) testing, inter alia, for the determination of the genetic sub-type of a patient; prognostic test reagents; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; reagents and other supplies for diagnostic testing; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells
35 Compilation of medical and veterinary information
44 Medical analysis services; analysis of medical and veterinary test scores and data for others; medical and veterinary information services provided via the internet
42 Scientific research for the benefit of the development of molecular diagnostic tests; developing software for performing diagnostic tests for medical purposes, as well as developing software and algorithms and / or databases for translation (reading), analyzing and interpreting test results; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers, testing, and (corresponding) methods of treatment; leasing of computer software for reading test results; development and testing services for the certification of quality or standards of (molecular) diagnostic tests
Color is not claimed as a feature of the mark.
Aug 6, 2022
Change Of Name/Address Rec'd From Ib
Nov 24, 2017
Final Decision Transaction Processed By Ib
Nov 9, 2017
Final Disposition Notice Sent To Ib
Nov 9, 2017
Final Disposition Notice Created, To Be Sent To Ib
Sep 15, 2017
Notification Of Possible Opposition - Processed By Ib
Aug 30, 2017
Notification Of Possible Opposition Sent To Ib
Aug 30, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 10, 2016
Abandonment Notice Mailed - Failure To Respond
Nov 9, 2016
Abandonment - Failure To Respond Or Late Response
May 14, 2016
Refusal Processed By Ib
Apr 1, 2016
Application Filing Receipt Mailed
Mar 31, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Mar 31, 2016
Refusal Processed By Mpu
Mar 31, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Mar 30, 2016
Non-Final Action Written
Mar 28, 2016
Assigned To Examiner
Mar 28, 2016
New Application Office Supplied Data Entered In Tram
Mar 24, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
